Primer: Simcere Pharmaceutical (2096 HK) - Aug 2026
Transition to Innovation Powerhouse: Simcere is successfully transitioning from a generic drug manufacturer to an R&D-driven pharmaceutical...
93 Views
𝛼SK or SearchENTITY
Simcere Pharmaceutical (2096 HK)
Simcere Pharmaceutical (2096 HK)
111
Analysis
Health Care • China
Simcere Pharmaceutical Group is an innovation and R&D-driven pharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical products. It focuses on therapeutic areas such as oncology, central nervous system diseases, autoimmune diseases, and anti-infection, with key products including Sanbexin, Endostar, and Bicun. The company was founded in 1995 and is headquartered in Nanjing, China.
morex